Creative Medical Technology (CELZ) vs Enveric Biosciences (ENVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Enveric Biosciences is the larger company by market cap ($6.8 million vs $6.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELZ | ENVB |
|---|---|---|
| Share price | $0.8604 | $1.52 |
| Market cap | $6.53M | $6.80M |
| 1-day change | -2.45% | +1.67% |
| EPS (TTM) | $-2.00 | $-13.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.25 | $13.25 |
| 52-week low | $0.62 | $1.17 |
| Distance from 52-week high | -86.23% | -88.53% |
| Analyst consensus | none | — |
| Avg. price target upside | +2224.50% | — |
| Average volume | 6.77M | 102.84K |
| Shares outstanding | 7.59M | 4.48M |
| Employees | 4 | 5 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Creative Medical Technology
CELZ stock →Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.
Healthcare · Biotechnology · 4 employees
About Enveric Biosciences
ENVB stock →Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
Healthcare · Biotechnology · 5 employees
CELZ vs ENVB FAQ
Which is bigger, Creative Medical Technology or Enveric Biosciences?
Enveric Biosciences (ENVB) is larger, with a market capitalization of $6.80M compared with $6.53M for Creative Medical Technology (CELZ).
Are Creative Medical Technology and Enveric Biosciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.